WhaleCreep
Home › Funds › StepStone Group LP › Q2 2025

StepStone Group LP 13F holdings, Q2 2025

Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →

StepStone Group LP disclosed 14 US equity positions worth $50.4m in its Q2 2025 13F filing. The largest position was PATH at 32.7% of the reported book, followed by DKNG and RBRK. Against the Q1 2025 filing, it opened 4 new positions, added to 1 and reduced 0 among the top 14 holdings.

← Q1 2025 · Q3 2025 →

What did StepStone Group LP own in Q2 2025? Top 14 positions

#StockSectorWeightValueSharesΔ sharesvs Q1 2025
1 PATH UIPATH, INC. Technology 32.7%$16.5m1,286,527 0% held
2 DKNG DRAFTKINGS INC Consumer Cyclical 18.2%$9.2m214,536 0% held
3 RBRK RUBRIK, INC. Technology 10.7%$5.4m60,182 12% added
4 TRDA ENTRADA THERAPEUTICS, INC. 10.1%$5.1m761,277 0% held
5 PHAT PHATHOM PHARMACEUTICALS, INC. 8.0%$4.0m422,085 0% held
6 NEUEHEALTH INC. 7.2%$3.6m525,247 0% held
7 HILLEVAX, INC. 3.3%$1.6m826,569 0% held
8 PAY PAYMENTUS HOLDINGS INC Technology 2.6%$1.3m39,573 – new
9 OKUR ONKURE THERAPEUTICS INC 2.3%$1.2m491,938 0% held
10 CXM SPRINKLR, INC. Technology 1.3%$635.5k75,116 – new
11 PDD PDD HOLDINGS INC. Consumer Cyclical 1.2%$625.8k7,032 – new
12 IOT SAMSARA INC. Technology 1.0%$484.9k12,189 – new
13 GROV GROVE COLLABORATIVE HOLDINGS, INC. 0.9%$437.8k380,702 0% held
14 TNYA TENAYA THERAPEUTICS, INC. 0.6%$282.4k462,163 0% held

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.